company background image
2020 logo

Zhejiang Jingxin Pharmaceutical SZSE:002020 Stock Report

Last Price

CN¥10.88

Market Cap

CN¥9.4b

7D

-3.7%

1Y

-13.2%

Updated

28 Mar, 2024

Data

Company Financials +

Zhejiang Jingxin Pharmaceutical Co., Ltd.

SZSE:002020 Stock Report

Market Cap: CN¥9.4b

Zhejiang Jingxin Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Jingxin Pharmaceutical
Historical stock prices
Current Share PriceCN¥10.88
52 Week HighCN¥16.16
52 Week LowCN¥8.28
Beta0.11
1 Month Change-0.46%
3 Month Change-14.47%
1 Year Change-13.17%
3 Year Change11.49%
5 Year Change15.85%
Change since IPO703.45%

Recent News & Updates

We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

Mar 29
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

Recent updates

We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

Mar 29
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

Shareholder Returns

2020CN PharmaceuticalsCN Market
7D-3.7%-3.1%-3.5%
1Y-13.2%-11.1%-15.8%

Return vs Industry: 002020 underperformed the CN Pharmaceuticals industry which returned -11.8% over the past year.

Return vs Market: 002020 exceeded the CN Market which returned -16.6% over the past year.

Price Volatility

Is 2020's price volatile compared to industry and market?
2020 volatility
2020 Average Weekly Movement6.1%
Pharmaceuticals Industry Average Movement7.1%
Market Average Movement8.2%
10% most volatile stocks in CN Market11.5%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 002020 has not had significant price volatility in the past 3 months.

Volatility Over Time: 002020's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19904,101Jin Zhipinghttps://www.jingxinpharm.com

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, Cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactate, levofloxacin hemihydrate, levofloxacin hydrochloride, levofloxacin lactate, enrofloxacin, enrofloxacin hydrochloride, simvastatin, rosuvastatin calcium, pitavastatin calcium, sitagliptin, clopidogrel bisulfate, ticagrelor, rivaroxaban, apixaban, sisapele, esomeprazole, levetiracetam, bovaracetam, sertraline hydrochloride, pramipexole hydrochloride, rivastigmine bitartrate, memantine hydrochloride, and paliperidone. It also provides intermediates; and medical display products, such as diagnostic medical displays, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, and ultrasonic medical displays.

Zhejiang Jingxin Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Jingxin Pharmaceutical's earnings and revenue compare to its market cap?
2020 fundamental statistics
Market capCN¥9.37b
Earnings (TTM)CN¥663.12m
Revenue (TTM)CN¥3.91b

14.1x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2020 income statement (TTM)
RevenueCN¥3.91b
Cost of RevenueCN¥1.92b
Gross ProfitCN¥1.98b
Other ExpensesCN¥1.32b
EarningsCN¥663.12m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Mar 30, 2024

Earnings per share (EPS)0.77
Gross Margin50.73%
Net Profit Margin16.98%
Debt/Equity Ratio6.9%

How did 2020 perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

39%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.